Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients

Diabetes

Volumn 48, Issue 3, 1999, Pages 484-490

  Roep, Bart O ^c   Stobbe, Inge ^d   Duinkerken, Gaby ^d   Van Rood, Jon J ^d   Lernmark, Åke ^a   Keymeulen, Bart ^b   Pipeleers, Danny ^b   Claas, Frans H J ^d   De Vries, René R P ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b DIABETES RESEARCH CENTER   (Belgium)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032971910     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.3.484     Document Type: Article

References (39)

1. Gores PF, Najaran JS, Stephanian E, Lloveras JJ, Kelley SL, Sutherland DE: Insulin independence in type I diabetes after transplantation of unpurified islets from single donor with 15-deoxyspergualin. Lancet 341:19-21, 1993
2. Ricordi C: Human islet cell transplantation: new perspectives for an old challenge. Diabetes Rev 4:356-369, 1996
3. Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV: Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:89-95, 1992
4. Warnork GL, Ryan EA, Kneteman NM, Ao Z, Lakey JR, Rajotte RV: The natural history of transplantation of insulin-producing pancreatic islets into type 1 diabetic patients. Transplant Proc 24:3058, 1992
5. Hering BJ, Geier C, Schultz AO, Bretzel RG, Federlin K: International Islet Transplantation Registry. Vol. 5. Giessen, Germany, Dept. of Medicine, Justus-Liebig University of Giessen, p. 1995, 1-28
6. Eisenbarth GS, Stegall M: Islet and pancreas transplantation: autoimmunity and alloimmunity. N Engl J Med 335:888-890, 1996
7. Sibley R, Sutherland DER, Goetz F, Michael AF: Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132-144, 1985
8. Sutherland DER, Goetz FC, Sibley RK: Recurrence of disease in pancreas transplants. Diabetes 38 (Suppl. 1):85-87, 1989
9. Tyden G, Reinholt FP, Sundkvist G, Bolinder J: Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 335:860-863, 1996
10. Bosi E, Bottazzo GF, Secchi A, Pozza G, Shattock M, Saunders A, Gelet A, Touraine JL, Traeger J, Dubernard J-M: Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation. Diabetes 38 (Suppl. 1):82-84, 1989
11. Rakotoambinina B, Timsit J, Deschamps I, Laborde K, Jos J, Boitard C, Assan R, Robert JJ: Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients. Diabetes Care 18:1487-1490, 1995
12. Keymeulen B, Ling Z, Gorus FK, Delvaux G, Bouwens L, Grupping A, Hendrieckx C, Pipeleers-Marichal M, Van Schravendijk C, Salmela K, Pipeleers DB: Implantation of standardized β-cell grafts in a liver segment of insulin-dependent diabetic patients: graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41:452-459, 1998
13. Roep BO, Arden SD, De Vries RRP, Hutton JC: T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature 345:632-634, 1990
14. Roep BO, Kallan AA, Hazenbos WL, Bruining GJ, Bailyes EM, Arden SD, Hutton JC, De Vries RRP: T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet 337:1439-1441, 1991
15. Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu DF, Erlander MG, Tobin AJ, Mclaren NK: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458-459, 1992
16. Worsaae A, Hejnaes K, Moody A, Ludvigsson J, Pociot F, Lorenzen T, Dyrberg T: T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity 22:183-189, 1995
17. Moody AJ, Hejnaes KR, Marshall MO, Larsen FS, Boel E, Svendsen I, Mortensen E, Dyrberg T: Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in sf9 insect cells. Diabetologia 38:14-23, 1995
18. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YL, Martin S, Martin A, Powers AC, Prochazka M, Naggert J, Leiter EH, Eisenbarth GS: Islet cell autoantigen 69 kD (ICA69): molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest 92:359-371, 1993
19. Roep BO, Duinkerken G, Schreuder GM, Kolb H, de Vries RR, Martin S: HLA-associated inverse congelation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol 26:1285-1289, 1996
20. Arden SD, Roep BO, Neophytou PI, Usac EF, Duinkerken G, de Vries RR, Hutton JC: Imogen 38: a novel 38-kd islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J Clin Invest 97:551-501, 1996
21. van Noort JM, van Sechel AC, Bajramovic JJ, el Ouagmiri M, Polman CH, Lassmann H, Ravid R: The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375:798-801, 1995
22. Karjalainen J, Martin JM, Knip M, Ilonen J, Robinson BH, Savilahti E, Åkerblom HK, Dosch HM: A bovine albumin peptide as possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 327:302-307, 1992
23. Roep BO, Kallan AA, Duinkerken G, Arden SD, Hutton JC, Bruining GJ, de Vries RR: T-cell reactivity to β-cell membrane antigens associated with β-cell destruction in IDDM. Diabetes 44:278-283, 1995
24. Bouma GJ, Schanz U, Oudshoorn M, Van der Meer-Prins PMW, Roelen DL, Van Rood JJ, Claas FHJ: A cell-saving non-radioactive limiting dilution analysis assay for the combined determination of helper and cytotoxic T-lymphocyte precursor frequencies. Bone Marrow Transplant 17:19-23, 1996
25. Bouma GJ, Van der Meer-Prins PMW, Van Bree FPMJ, Van Rood JJ, Claas FHJ: Determination of cytotoxic T-lymphocyte precursor frequencies using Europium labeling as a nonradioactive alternative to labeling with chromium-51. Hum Immunol 35:85-92, 1992
26. Strijbosch LWG, Buurman WA, Does RJMM, Zinken PH, Groenewegen G: Limiting dilution assays: experimental design and statistical analysis. J Immunol Methods 97:133-140, 1987
27. Schanz U, Roelen DL, Bruning JW, Kardol MJ, Van Rood JJ, Claas FHJ: The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods 169:221-230, 1994
28. Heeg K, Steeg C, Wagner H: High dose irradiated splenic stimulator cells show no endogenous interleukin-2 production but stimulate clonally developing helper T-cells to produce interleukin-2. J Immunol Methods 109:185-191, 1988
29. Lin Y, Langmann R, Cohn M: The priming of cytotoxic T-cell precursors is strictly helper T cell-dependent. Scand J Immunol 35:621-626, 1992
30. + T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients. Transplantation 52:284-291, 1991
31. Van Besouw NM, Vaessen LMB, Daane CR, Jutte NHPM, Balk AGMM, Claas FHJ, Weimar W: Peripheral monitoring of direct and indirect alloantigen presentation pathways in clinical heart transplant recipients. Transplantation 61:165-167, 1996
32. Calafiore R, Basta G, Falorni A, Ietropaolo M, Picchio ML, Calcinaro F, Brunetti P: Preventive effects of azathioprine (AZA) on the onset of diabetes mellitus in NOD mice. J Endocrinol Invest 16:869-873, 1993
33. Cook JJ, Hudson I, Harrison LC, Dean B, Colman PG, Werther GA, Warne GL, Court JM: Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes. Diabetes 38:779-783, 1989
34. Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S: Immunosuppression with azathioprine and prednisone in recent onset insulin-dependent diabetes mellitus. N Engl J Med 319:599-604, 1988
35. Harrison LC, Colman PG, Dean B, Baxter R, Martin FIR: Increase in remission rate in newly diagnosed type 1 diabetic subjects treated with azathioprine. Diabetes 34:1306-1308, 1985
36. Ouwehand AJ, Baan CC, Roelen DL, Vaessen LMB, Balk AHMM, Jutte NHPM, Bos E, Claas FHJ, Weimar W: The detection of cytotoxic T-cells with high affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation 56:1223-1229, 1993
37. Jaeger C, Hering BJ, Dyrberg T, Federlin K, Bretzel RG: Islet cell antibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after-kidney transplantation. Transplantation 62:424-426, 1996
38. Olack BJ, Swanson CJ, Flavin KS, Phelan D, Brennan DC, White NH, Lacy PE, Scharp DW, Poindexter N, Mohanakumar T: Sensitization to HLA antigens in islet recipients with failing transplants. Transplant Proc 29:2268-2269, 1997
39. Secchi A, Socci S, Maffi P, Taglietti MV, Falqui L, Bertuzzi E: Islet transplantation in IDDM patients. Diabetologia 40:225-231, 1997